Bladder Cancer
Showing NaN - NaN of 50
Urothelial Carcinoma, Bladder Cancer Trial in United States (drug, radiation, biological)
Recruiting
- Urothelial Carcinoma
- Bladder Cancer
- Durvalumab (Cohort 1-3)
- +7 more
-
Phoenix, Arizona
- +10 more
Jan 11, 2023
Bladder Cancer Trial in Worldwide (Atezolizumab)
Active, not recruiting
- Bladder Cancer
-
Birmingham, Alabama
- +76 more
Dec 6, 2022
Bladder Cancer Trial in Worldwide (Atezolizumab)
Active, not recruiting
- Bladder Cancer
-
Birmingham, Alabama
- +76 more
Dec 6, 2022
Intravesical Therapy and Surgery as Treatment Options for
Recruiting
- Bladder Cancer
- +2 more
-
Birmingham, Alabama
- +37 more
Nov 28, 2022
Biomarkers in Subjects With Untreated Solid Tumors
Completed
- Breast Cancer
- +12 more
- Blood Sample Collection
-
Phoenix, Arizona
- +118 more
Aug 31, 2022
NSCLC, Renal Cell Cancer, Colorectal Cancer Trial in Australia, United States (CPI-006, CPI-006 + ciforadenant, CPI-006 +
Active, not recruiting
- Non-Small Cell Lung Cancer
- +12 more
- CPI-006
- +2 more
-
Tucson, Arizona
- +26 more
Aug 1, 2022
Bladder Cancer Trial in Canada, United States (therapeutic conventional surgery, therapeutic standard lymphadenectomy,
Active, not recruiting
- Bladder Cancer
- therapeutic conventional surgery
- +2 more
-
Los Angeles, California
- +34 more
Jul 20, 2022
Urothelial Carcinoma, Bladder Cancer, Urethral Cancer Trial in United States (Biospecimen Collection)
Active, not recruiting
- Urothelial Carcinoma
- +3 more
- Biospecimen Collection
-
Los Angeles, California
- +7 more
Feb 14, 2022
Prostate Cancer, Melanoma, Renal Cell Carcinoma Trial in United States (MGA271)
Completed
- Prostate Cancer
- +6 more
- MGA271
-
Los Angeles, California
- +11 more
Feb 4, 2022
Urothelial Carcinoma, Urothelial Carcinoma Bladder, Bladder Cancer Trial in United States (IK-175, IK-175 and nivolumab)
Recruiting
- Urothelial Carcinoma
- +20 more
- IK-175
- IK-175 and nivolumab
-
Gilbert, Arizona
- +9 more
Feb 3, 2022
Bladder Cancer Trial in United States (Gemcitabine, Cisplatin, Methotrexate)
Bladder Cancer Trial in United States (Atezolizumab, Bacille Calmette-Guérin)
Terminated
- Bladder Cancer
- Atezolizumab
- Bacille Calmette-Guérin
-
Stanford, California
- +7 more
Sep 29, 2021
Bladder Cancer Trial in United States (CG0070)
Completed
- Bladder Cancer
- CG0070
-
Anchorage, Alaska
- +16 more
Apr 12, 2021
Transitional Cell Carcinoma, Bladder Cancer, Carcinoma in Situ Trial in United States (CG0070 Adenovirus Vector, Control Arm:
Terminated
- Transitional Cell Carcinoma
- +3 more
- CG0070 Adenovirus Vector
- Control Arm: Quadruple Choice
-
Phoenix, Arizona
- +6 more
Apr 12, 2021
Bladder Cancer Trial in United States (Post-Operative Recovery Registry)
Recruiting
- Bladder Cancer
- Post-Operative Recovery Registry
-
San Francisco, California
- +10 more
Dec 1, 2020
Prostate Cancer, Kidney Cancer, Bladder Cancer Trial in Chicago, Evanston (Text or email message)
Completed
- Prostate Cancer
- +2 more
- Text or email message
-
Chicago, Illinois
- +1 more
Feb 21, 2019
Urinary Sediment in Detecting Bladder Cancer
Completed
- Bladder Cancer
- loss of heterozygosity analysis
- +6 more
-
Birmingham, Alabama
- +12 more
Feb 6, 2019
Bladder Cancer Trial in United States (Hexaminolevulinate HCl, KARL STORZ D-Light C PDD Flexible Videoscope System)
Completed
- Bladder Cancer
- Hexaminolevulinate hydrochloride
- KARL STORZ D-Light C PDD Flexible Videoscope System
-
Los Angeles, California
- +16 more
May 31, 2018